Nitrosamines are a group of carcinogens widely occurring in the environment. It is known that metabolic activation is required for their carcinogenic actions. The enzymology of and factors affecting the metabolism of nitrosamines, however, are not clearly understood. Recent work in our laboratory has demonstrated the presence of a cytochrome P-450 (P-450)-mediated high affinity N-nitrosodimethylamine (NDMA) demethylase in rat liver microsomes inducible by fasting, diabetes, acetone, isopropanol, ethanol, and pyrazole. Our working hypothesis is that specific P-450 isozymes, inducible by the above factors, are responsible for the metabolism of NDMA and probably also other nitrosamines. In this proposal several lines of research will be pursued: 1. To purify the P-450 isozymes with high affinity and activity toward nitrosamines from rat liver microsomes. These P-450 isozymes will be characterized and compared with known P-450 isozymes in terms of their substrate specificities and other molecular properties. 2. To investigate the substrate specificity and mechanisms of nitrosamine metabolism (activation) by purified P-450 isozymes. The Km values of NDMA demethylase as well as the nature of the oxygenation, denitrosation and other reactions will be investigated. 3. To study the distribution and induction of the specific P-450 isozymes as well as their roles in nitrosamine metabolism in liver and nonhepatic tissues by immunochemical techniques and enzyme assays. 4. To illustrate the biological consequences of the induction of NDMA demethylase by measuring in vivo DNA alkylation in different organs. Nitrosamine metabolism in vivo and activation in model systems will be studied to provide additional mechanistic insights into the activation process. It is hoped that the proposed studies will yield definitive information on the enzymology and mechanisms of nitrosamine metabolism. Such information is crucial to our understanding of the carcinogenicity of nitrosamines and the modification of carcinogenesis by nutritional and environmental factors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037037-03
Application #
3174714
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1984-02-15
Project End
1987-01-31
Budget Start
1986-02-01
Budget End
1987-01-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Type
Schools of Medicine
DUNS #
605799469
City
Newark
State
NJ
Country
United States
Zip Code
07107
Smith, T J; Liao, A; Wang, L D et al. (1998) Characterization of xenobiotic-metabolizing enzymes and nitrosamine metabolism in the human esophagus. Carcinogenesis 19:667-72
Wang, L D; Zhou, Q; Hong, J Y et al. (1996) p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China. Cancer 77:1244-9
Smith, T J; Guo, Z; Guengerich, F P et al. (1996) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis 17:809-13
Ardies, C M; Smith, T J; Kim, S et al. (1996) Induction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) activation in rat lung microsomes by chronic ethanol consumption and repeated running exercise. Cancer Lett 103:209-18
Smith, T J; Hong, J Y; Wang, Z Y et al. (1995) How can carcinogenesis be inhibited? Ann N Y Acad Sci 768:82-90
Smith, T J; Stoner, G D; Yang, C S (1995) Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res 55:5566-73
Yang, C S; Smith, T J; Hong, J Y (1994) Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res 54:1982s-1986s
Wang, L D; Shi, S T; Zhou, Q et al. (1994) Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer 59:514-9
Gao, H; Wang, L D; Zhou, Q et al. (1994) p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 54:4342-6
Wang, L D; Hong, J Y; Qiu, S L et al. (1993) Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 53:1783-7

Showing the most recent 10 out of 61 publications